 Jason Aoto
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 11 | 2024 | 596 | 3.200 |
Why?
| | Synapses | 16 | 2025 | 427 | 2.690 |
Why?
| | Hippocampus | 16 | 2025 | 895 | 2.580 |
Why?
| | Receptors, AMPA | 10 | 2025 | 141 | 1.750 |
Why?
| | Synaptic Transmission | 11 | 2024 | 289 | 1.710 |
Why?
| | Neurons | 10 | 2024 | 1590 | 1.550 |
Why?
| | Cell Adhesion Molecules, Neuronal | 4 | 2024 | 41 | 1.330 |
Why?
| | Interneurons | 3 | 2021 | 122 | 0.970 |
Why?
| | GABAergic Neurons | 1 | 2021 | 35 | 0.720 |
Why?
| | Nucleus Accumbens | 1 | 2023 | 138 | 0.710 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 88 | 0.690 |
Why?
| | Neural Inhibition | 1 | 2021 | 169 | 0.680 |
Why?
| | Cytological Techniques | 1 | 2020 | 27 | 0.660 |
Why?
| | Synaptic Vesicles | 2 | 2019 | 44 | 0.660 |
Why?
| | Protein Aggregates | 1 | 2020 | 72 | 0.630 |
Why?
| | Calcium | 3 | 2023 | 1199 | 0.630 |
Why?
| | Cell Communication | 1 | 2020 | 315 | 0.580 |
Why?
| | Anxiety | 1 | 2025 | 1035 | 0.560 |
Why?
| | Stress, Psychological | 1 | 2025 | 1100 | 0.520 |
Why?
| | Mice | 17 | 2025 | 17787 | 0.500 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2023 | 198 | 0.500 |
Why?
| | Alternative Splicing | 2 | 2019 | 229 | 0.490 |
Why?
| | Olfactory Bulb | 2 | 2015 | 93 | 0.460 |
Why?
| | Long-Term Potentiation | 4 | 2025 | 198 | 0.450 |
Why?
| | Animals | 23 | 2025 | 36940 | 0.440 |
Why?
| | Neuronal Plasticity | 4 | 2024 | 290 | 0.400 |
Why?
| | HEK293 Cells | 5 | 2024 | 730 | 0.380 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2024 | 124 | 0.370 |
Why?
| | Tretinoin | 2 | 2008 | 123 | 0.350 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5757 | 0.350 |
Why?
| | Mutation, Missense | 2 | 2024 | 341 | 0.330 |
Why?
| | Cells, Cultured | 8 | 2024 | 4193 | 0.330 |
Why?
| | Ligands | 2 | 2023 | 664 | 0.320 |
Why?
| | Glutamic Acid | 3 | 2023 | 246 | 0.320 |
Why?
| | Endocytosis | 2 | 2025 | 172 | 0.310 |
Why?
| | Neural Cell Adhesion Molecules | 3 | 2019 | 32 | 0.300 |
Why?
| | Sex Characteristics | 2 | 2025 | 762 | 0.290 |
Why?
| | Pyramidal Cells | 1 | 2008 | 74 | 0.290 |
Why?
| | Ephrin-B3 | 1 | 2007 | 1 | 0.280 |
Why?
| | Ephrins | 1 | 2006 | 8 | 0.270 |
Why?
| | Behavior, Animal | 3 | 2025 | 501 | 0.260 |
Why?
| | Epilepsy | 2 | 2021 | 333 | 0.250 |
Why?
| | Rats | 5 | 2024 | 5647 | 0.250 |
Why?
| | Mice, Knockout | 4 | 2021 | 3015 | 0.240 |
Why?
| | Parvalbumins | 2 | 2024 | 25 | 0.240 |
Why?
| | Receptors, Adrenergic | 1 | 2025 | 33 | 0.240 |
Why?
| | Restraint, Physical | 1 | 2025 | 72 | 0.240 |
Why?
| | Septal Nuclei | 1 | 2025 | 23 | 0.240 |
Why?
| | Protein Transport | 3 | 2024 | 445 | 0.230 |
Why?
| | Acyltransferases | 1 | 2025 | 57 | 0.230 |
Why?
| | Globus Pallidus | 1 | 2024 | 26 | 0.220 |
Why?
| | Corticosterone | 1 | 2025 | 236 | 0.220 |
Why?
| | Memory Disorders | 1 | 2025 | 164 | 0.210 |
Why?
| | Ventral Tegmental Area | 1 | 2024 | 58 | 0.210 |
Why?
| | Calcium-Binding Proteins | 4 | 2019 | 218 | 0.210 |
Why?
| | Structure-Activity Relationship | 1 | 2024 | 570 | 0.210 |
Why?
| | Signal Transduction | 6 | 2016 | 5079 | 0.200 |
Why?
| | Receptors, Dopamine | 1 | 2023 | 20 | 0.200 |
Why?
| | Cocaine | 1 | 2024 | 166 | 0.190 |
Why?
| | Receptors, GABA-A | 1 | 2023 | 142 | 0.190 |
Why?
| | Endoplasmic Reticulum | 1 | 2024 | 265 | 0.190 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2021 | 7 | 0.190 |
Why?
| | Optogenetics | 2 | 2023 | 108 | 0.180 |
Why?
| | Male | 9 | 2025 | 67762 | 0.180 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2021 | 45 | 0.180 |
Why?
| | Protein Binding | 2 | 2024 | 2224 | 0.180 |
Why?
| | Autistic Disorder | 2 | 2015 | 204 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 188 | 0.180 |
Why?
| | Parasympathetic Nervous System | 1 | 2021 | 27 | 0.170 |
Why?
| | Motor Disorders | 1 | 2021 | 15 | 0.170 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 35 | 0.170 |
Why?
| | Substantia Nigra | 1 | 2021 | 57 | 0.170 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 327 | 0.170 |
Why?
| | Mutation | 3 | 2024 | 3958 | 0.170 |
Why?
| | Cell Aggregation | 1 | 2020 | 26 | 0.170 |
Why?
| | Female | 7 | 2025 | 73304 | 0.160 |
Why?
| | Astrocytes | 1 | 2021 | 210 | 0.160 |
Why?
| | Dimerization | 1 | 2019 | 199 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.150 |
Why?
| | Genetic Engineering | 1 | 2019 | 93 | 0.150 |
Why?
| | Peptides | 1 | 2025 | 985 | 0.150 |
Why?
| | Lipoylation | 1 | 2018 | 17 | 0.150 |
Why?
| | Integrases | 1 | 2019 | 120 | 0.150 |
Why?
| | Receptors, Retinoic Acid | 2 | 2008 | 43 | 0.150 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 181 | 0.150 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 78 | 0.150 |
Why?
| | Botulinum Toxins | 1 | 2019 | 41 | 0.150 |
Why?
| | Recombination, Genetic | 1 | 2019 | 204 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1164 | 0.140 |
Why?
| | Gene Knock-In Techniques | 2 | 2019 | 56 | 0.140 |
Why?
| | A Kinase Anchor Proteins | 1 | 2018 | 72 | 0.140 |
Why?
| | Intellectual Disability | 1 | 2019 | 165 | 0.140 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 219 | 0.130 |
Why?
| | Protein Biosynthesis | 2 | 2008 | 433 | 0.120 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 181 | 0.120 |
Why?
| | Capillaries | 3 | 2005 | 108 | 0.110 |
Why?
| | Endocannabinoids | 1 | 2015 | 63 | 0.110 |
Why?
| | Models, Biological | 2 | 2015 | 1783 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 452 | 0.110 |
Why?
| | Neural Pathways | 1 | 2015 | 295 | 0.100 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 313 | 0.100 |
Why?
| | Neovascularization, Physiologic | 2 | 2005 | 179 | 0.100 |
Why?
| | Humans | 14 | 2025 | 137585 | 0.100 |
Why?
| | Retinoic Acid Receptor alpha | 2 | 2008 | 17 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2023 | 771 | 0.090 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 3 | 2019 | 243 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2012 | 483 | 0.080 |
Why?
| | Cryptochromes | 2 | 2019 | 25 | 0.080 |
Why?
| | Transfection | 2 | 2008 | 945 | 0.080 |
Why?
| | Arabidopsis Proteins | 2 | 2019 | 75 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2008 | 156 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2486 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2008 | 286 | 0.070 |
Why?
| | Receptor, Notch1 | 2 | 2005 | 64 | 0.070 |
Why?
| | Dendrites | 1 | 2008 | 105 | 0.070 |
Why?
| | Receptors, Notch | 2 | 2005 | 88 | 0.070 |
Why?
| | Electrophysiology | 1 | 2007 | 217 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2007 | 443 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 332 | 0.060 |
Why?
| | Mental Disorders | 1 | 2015 | 1077 | 0.060 |
Why?
| | Light | 2 | 2019 | 381 | 0.060 |
Why?
| | Fluorescent Dyes | 2 | 2024 | 321 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2008 | 622 | 0.060 |
Why?
| | Up-Regulation | 1 | 2008 | 843 | 0.060 |
Why?
| | Pinocytosis | 1 | 2025 | 11 | 0.060 |
Why?
| | Neurotransmitter Agents | 2 | 2015 | 81 | 0.060 |
Why?
| | KCNQ3 Potassium Channel | 1 | 2024 | 3 | 0.060 |
Why?
| | KCNQ Potassium Channels | 1 | 2024 | 4 | 0.060 |
Why?
| | Homeostasis | 1 | 2008 | 621 | 0.060 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2024 | 59 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 455 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1738 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 545 | 0.050 |
Why?
| | Receptors, Neurotransmitter | 1 | 2023 | 18 | 0.050 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 69 | 0.050 |
Why?
| | Angiopoietin-1 | 1 | 2003 | 11 | 0.050 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2003 | 24 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2025 | 261 | 0.050 |
Why?
| | Memory | 1 | 2025 | 248 | 0.050 |
Why?
| | Fibrin | 1 | 2003 | 81 | 0.050 |
Why?
| | Epitopes | 1 | 2024 | 479 | 0.050 |
Why?
| | Fibroblasts | 2 | 2003 | 996 | 0.050 |
Why?
| | Neostriatum | 1 | 2021 | 33 | 0.040 |
Why?
| | Acetylcholine | 1 | 2021 | 185 | 0.040 |
Why?
| | Umbilical Veins | 3 | 2005 | 62 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1353 | 0.040 |
Why?
| | Brain Injuries | 1 | 2025 | 494 | 0.040 |
Why?
| | Learning | 1 | 2023 | 409 | 0.040 |
Why?
| | RNA Splice Sites | 1 | 2019 | 45 | 0.040 |
Why?
| | Vesicle-Associated Membrane Protein 2 | 1 | 2019 | 14 | 0.040 |
Why?
| | SNARE Proteins | 1 | 2019 | 39 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1759 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2018 | 65 | 0.040 |
Why?
| | Dopamine | 1 | 2021 | 303 | 0.040 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 136 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1430 | 0.030 |
Why?
| | Endosomes | 1 | 2018 | 136 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2003 | 927 | 0.030 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 58 | 0.030 |
Why?
| | Exocytosis | 1 | 2016 | 89 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2015 | 10 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1357 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2015 | 70 | 0.030 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 25 | 0.030 |
Why?
| | Glycerides | 1 | 2015 | 21 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2019 | 306 | 0.030 |
Why?
| | Gene Targeting | 1 | 2015 | 81 | 0.030 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 15 | 0.030 |
Why?
| | Arachidonic Acids | 1 | 2015 | 62 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 118 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2016 | 466 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 293 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 409 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1502 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 305 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 363 | 0.020 |
Why?
| | Cell Membrane | 1 | 2015 | 738 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2139 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 469 | 0.020 |
Why?
| | Nerve Net | 1 | 2012 | 256 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1774 | 0.020 |
Why?
| | Cytoplasmic Granules | 1 | 2008 | 93 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1991 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3196 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2005 | 27 | 0.010 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2005 | 29 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 50 | 0.010 |
Why?
| | Endopeptidases | 1 | 2005 | 90 | 0.010 |
Why?
| | Carbamates | 1 | 2005 | 50 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2005 | 112 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2005 | 177 | 0.010 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2005 | 80 | 0.010 |
Why?
| | Placenta Growth Factor | 1 | 2003 | 24 | 0.010 |
Why?
| | Receptor, Notch4 | 1 | 2003 | 3 | 0.010 |
Why?
| | Pregnancy Proteins | 1 | 2003 | 36 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2003 | 75 | 0.010 |
Why?
| | Blood Vessels | 1 | 2005 | 187 | 0.010 |
Why?
| | Flavonoids | 1 | 2003 | 85 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 134 | 0.010 |
Why?
| | Gels | 1 | 2003 | 80 | 0.010 |
Why?
| | Microspheres | 1 | 2003 | 137 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 382 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 152 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 794 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 185 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 976 | 0.010 |
Why?
| | Adenoviridae | 1 | 2003 | 193 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 179 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 313 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 390 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2003 | 204 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 385 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 840 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 648 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 785 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2057 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 967 | 0.010 |
Why?
| | Skin | 1 | 2003 | 752 | 0.010 |
Why?
| | Cell Line | 1 | 2003 | 2847 | 0.010 |
Why?
| | Transcription Factors | 1 | 2003 | 1719 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2003 | 6079 | 0.010 |
Why?
|
|
Aoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|